From the current website
Unclaimedanesiva.com
Anesiva » Anesiva – Biopharmaceutical Innovations
Anesiva (Nasdaq: ANSV) is a late-stage biopharmaceutical company developing novel pharmaceutical products for pain management and diet-related conditions. The company's pipeline includes Adlea for post-surgical pain and Nexletol for diet management. As of 2008, Anesiva had advanced clinical programs and was pursuing regulatory approval for its lead candidates.
Suggest official facts
Correct a description, link or other detail. Submissions are reviewed before publication.